Oncimmune Holdings (ONC)

 25.20p
   
  • Change Today:
      0.000p
  • 52 Week High: 40.60
  • 52 Week Low: 15.10
  • Currency: UK Pounds
  • Shares Issued: 74.14m
  • Volume: 33,374
  • Market Cap: £18.68m

ONC Overview

We are leaders in immune biomarkers; our vision is to enable personalised, data-driven clinical decisions across the cancer care continuum. Using our unique expertise and proprietary technology we aim to transform the way disease is diagnosed and treated around the world. We know that detecting the disease early can improve the ability to treat cancer and enhance chances of survival.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -340.6% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 16.2 n/a
Pr/Book 28.4  
Latest F'cast
Revenue -37.7% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

ONC Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-May-19 0.17 (8.55) (12.97)p n/a n/a n/a n/a 0.0%
31-May-20 0.51 (9.78) (13.36)p n/a n/a n/a n/a 0.0%
31-May-21 3.72 (6.06) (7.73)p n/a n/a n/a n/a 0.0%
31-Aug-22 2.32 (6.58) (7.91)p n/a n/a n/a n/a 0.0%
31-Aug-23 1.15 (5.93) (8.47)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

ONC Company Announcements

Result of General Meeting 02-Apr-2024 11:34 RNS
Total Voting Rights 02-Apr-2024 08:00 RNS
Holding(s) in Company 26-Mar-2024 11:18 RNS

ONC ShareCast News

Oncimmune revenue falls as it implements new str... 29-Feb-2024 ShareCast
Oncimmune sells 'non-core' lung and antibody ass... 22-May-2023 ShareCast
Oncimmune enters collaboration with Siemens Heal... 17-Feb-2023 ShareCast

Latest ONC Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

ONC Market Data

Currency UK Pounds
Share Price 25.20p
Change Today 0.000p
% Change 0.00 %
52 Week High 40.60
52 Week Low 15.10
Volume 33,374
Shares Issued 74.14m
Market Cap £18.68m

ONC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

ONC Dividends

No dividends found

Trades for 16-Apr-2024

Time Volume / Share Price
09:45 30,000 @ 26.46p
08:22 3,374 @ 24.14p

ONC Key Personnel

CEO Martin Gouldstone

Top of Page